Lara Sanvito

Summary

Publications

  1. ncbi Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy
    Lara Sanvito
    Department of Clinical Neuroscience, King s College London, Guy s Hospital, London, UK
    Autoimmunity 42:667-77. 2009
  2. ncbi Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroids
    Lara Sanvito
    Division of Clinical Neurology, University of Nottingham, Nottingham, United Kingdom
    J Neuroimmunol 236:111-7. 2011
  3. ncbi TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function
    Mukanthu H Nyirenda
    Division of Clinical Neurology, University of Nottingham, Nottingham NG7 2UH, United Kingdom
    J Immunol 187:2278-90. 2011
  4. ncbi Novel therapeutic approaches to autoimmune demyelinating disorders
    Lara Sanvito
    Division of Clinical Neurology, University of Nottingham, United Kingdom
    Curr Pharm Des 17:3191-201. 2011
  5. ncbi Characterization of a monoclonal antibody specific for human peripheral myelin protein 22 and its use in immunohistochemical studies of the fetal and adult nervous system
    Norman A Gregson
    Department of Clinical Neuroscience, King s College London School of Medicine, Guy s Hospital, London, UK
    J Peripher Nerv Syst 12:2-10. 2007
  6. ncbi Modulation of regulatory T cells in health and disease: role of toll-like receptors
    Mukanthu H Nyirenda
    Division of Clinical Neurology, University of Nottingham, UK
    Inflamm Allergy Drug Targets 8:124-9. 2009

Collaborators

Detail Information

Publications6

  1. ncbi Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy
    Lara Sanvito
    Department of Clinical Neuroscience, King s College London, Guy s Hospital, London, UK
    Autoimmunity 42:667-77. 2009
    ..Myelin protein peptides were not the target of the altered peripheral regulation of the immune response. The mechanisms of peripheral immune tolerance in CIDP and their relevance to the pathogenesis deserve further exploration...
  2. ncbi Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroids
    Lara Sanvito
    Division of Clinical Neurology, University of Nottingham, Nottingham, United Kingdom
    J Neuroimmunol 236:111-7. 2011
    ..This study, although limited, shows that treatment with IFN-β affects NK cell cycle without altering NK cell apoptosis in MS patients...
  3. ncbi TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function
    Mukanthu H Nyirenda
    Division of Clinical Neurology, University of Nottingham, Nottingham NG7 2UH, United Kingdom
    J Immunol 187:2278-90. 2011
    ..Such TLR-induced mechanism of regulation of Treg function could enhance microbial clearance and increase the risk of autoimmune reactions...
  4. ncbi Novel therapeutic approaches to autoimmune demyelinating disorders
    Lara Sanvito
    Division of Clinical Neurology, University of Nottingham, United Kingdom
    Curr Pharm Des 17:3191-201. 2011
    ..Extension studies for most of the new drugs are under way and will provide evidence on the efficacy and long term effects of the new treatment strategies...
  5. ncbi Characterization of a monoclonal antibody specific for human peripheral myelin protein 22 and its use in immunohistochemical studies of the fetal and adult nervous system
    Norman A Gregson
    Department of Clinical Neuroscience, King s College London School of Medicine, Guy s Hospital, London, UK
    J Peripher Nerv Syst 12:2-10. 2007
    ..PMP22 reactivity was detected in the spinal roots of the human fetus at 19-20 weeks of gestation. The staining pattern of the PMP22 antibody resembled that of a monoclonal antibody directed against the myelin protein zero...
  6. ncbi Modulation of regulatory T cells in health and disease: role of toll-like receptors
    Mukanthu H Nyirenda
    Division of Clinical Neurology, University of Nottingham, UK
    Inflamm Allergy Drug Targets 8:124-9. 2009
    ..Understanding the link between Tregs and TLR could be beneficial to the discovery of new therapeutic targets and strategies...